{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:38:06Z","timestamp":1784216286641,"version":"3.55.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":141,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Buerger's disease or thromboangiitis obliterans is a type of obstructive vascular diseases categorized as vasculitis and usually present in 95% of young smoker men. The main pathogenetic mechanism is interplay between immune system and inflammation. Earlier our phase II study has shown that Stempeucel is safe when injected at 2 million cells\/kg body weight by virtue of its anti-inflammatory, immunomodulatory, and angiogenetic properties. The present study was conducted to further assess the safety and efficacy of Stempeucel in critical limb ischemia due to Buerger's disease after obtaining approval from Indian FDA based on the data generated in the phase II study. This is an open label, multicenteric phase IV PMS study conducted across India with experienced vascular surgeons. Fifty patients of critical limb ischemia due to Buerger's disease with Rutherford III-5 or III-6 were included in the study and each individual received a dose of 2 million cells\/kg body weight of Stempeucel in the calf muscles and around the ulcer. These patients were evaluated over 12 months from drug administration. The present study showed the continued long term efficacy over a period of 12 months follow up in these patients corroborating the result obtained in the previous phase II studies. There was significant improvement in rest pain, ankle systolic pressure, and ankle brachial pressure index with accelerated ulcer healing. In conclusion, the present study shows that the intramuscular administration of Stempeucel continues to be safe, tolerable, and effective alternative treatment in patients with Buerger's disease.<\/jats:p>","DOI":"10.1002\/sctm.21-0197","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T04:39:36Z","timestamp":1631594376000},"page":"1602-1613","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Phase IV Postmarketing Surveillance Study Shows Continued Efficacy and Safety of Stempeucel in Patients with Critical Limb Ischemia Due to Buerger's Disease"],"prefix":"10.1093","volume":"10","author":[{"given":"Pawan Kumar","family":"Gupta","sequence":"first","affiliation":[{"name":"Stempeutics Research Pvt. Ltd , Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santanu","family":"Dutta","sequence":"additional","affiliation":[{"name":"Belle Vue Clinic , Kolkata, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kala","sequence":"additional","affiliation":[{"name":"GSVM Medical College , Kanpur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muralikrishna","family":"Nekkanti","sequence":"additional","affiliation":[{"name":"Sri Jayadeva Institute of Cardiovascular Sciences and Research , Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay C.","family":"Desai","sequence":"additional","affiliation":[{"name":"M.S. Ramaiah Medical College & Hospitals , Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhendu S.","family":"Mahapatra","sequence":"additional","affiliation":[{"name":"Health Point Hospital , Kolkata, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Dhar","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences , New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhakrishnan","family":"Raju","sequence":"additional","affiliation":[{"name":"Sri Ramachandra Medical Centre , Chennai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajkumar","family":"M.","sequence":"additional","affiliation":[{"name":"Vijaya Hospital , Chennai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunanshu","family":"Behera","sequence":"additional","affiliation":[{"name":"Post-Graduate Institute of Medical Education & Research , Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6968-6432","authenticated-orcid":false,"given":"Shivashankar","family":"P.","sequence":"additional","affiliation":[{"name":"Stempeutics Research Pvt. Ltd , Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.S.","family":"Raviraja","sequence":"additional","affiliation":[{"name":"Stempeutics Research Pvt. Ltd , Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pachaiyappan","family":"Viswanathan","sequence":"additional","affiliation":[{"name":"Stempeutics Research Pvt. Ltd , Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithun","family":"Chandrashekar","sequence":"additional","affiliation":[{"name":"Stempeutics Research Pvt. Ltd , Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charan","family":"Thej","sequence":"additional","affiliation":[{"name":"Stempeutics Research Pvt. Ltd , Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanth","family":"K.V.","sequence":"additional","affiliation":[{"name":"Stempeutics Research Pvt. Ltd , Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijy","family":"Abraham","sequence":"additional","affiliation":[{"name":"Stempeutics Research Pvt. Ltd , Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hema","family":"Boggarapu","sequence":"additional","affiliation":[{"name":"Stempeutics Research Pvt. Ltd , Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Udaykumar","sequence":"additional","affiliation":[{"name":"Stempeutics Research Pvt. Ltd , Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"key":"2022061713355846100_sct313020-bib-0001","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1750-1172-1-14","article-title":"Thromboangiitis obliterans (Buerger's disease)","volume":"1","author":"Arkkila","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"2022061713355846100_sct313020-bib-0002","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/230780","article-title":"Chronic ulcers in thromboangiitis obliterans (Buerger's disease): updating epidemiology, physiopathology, and bosentan\u2014a novel strategy of therapy","volume":"2013","author":"L\u00f3pez de Maturana","year":"2013","journal-title":"Ulcers"},{"key":"2022061713355846100_sct313020-bib-0003","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.110.942383","article-title":"Thromboangiitis obliterans","volume":"121","author":"Piazza","year":"2010","journal-title":"Circulation"},{"key":"2022061713355846100_sct313020-bib-0004","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1067\/mva.1991.28408","article-title":"Urinary cotinine measurement in patients with Buerger's disease\u2014effects of active and passive smoking on the disease process","volume":"14","author":"Uhl","year":"1991","journal-title":"J Vasc Surg"},{"key":"2022061713355846100_sct313020-bib-0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jvs.2005.03.016","article-title":"Oral bacteria in the occluded arteries of patients with Buerger disease","volume":"42","author":"Iwai","year":"2005","journal-title":"J Vasc Surg"},{"issue":"suppl 5","key":"2022061713355846100_sct313020-bib-0006","first-page":"3","article-title":"The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease)","volume":"82","author":"Olin","year":"1990","journal-title":"Circulation"},{"key":"2022061713355846100_sct313020-bib-0007","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1056\/NEJM200009213431207","article-title":"Thromboangiitis obliterans (Buerger's disease)","volume":"343","author":"Olin","year":"2000","journal-title":"N Engl J Med"},{"key":"2022061713355846100_sct313020-bib-0008","doi-asserted-by":"crossref","first-page":"689","DOI":"10.5966\/sctm.2016-0237","article-title":"Administration of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells in critical limb ischemia due to Buerger's disease: phase II study report suggests clinical efficacy","volume":"6","author":"Gupta","year":"2017","journal-title":"Stem Cells Translational Medicine"},{"key":"2022061713355846100_sct313020-bib-0009","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/145749690809700108","article-title":"Treatment with autologous bone marrow mononuclear cells in patients with critical lower limb ischaemia. A pilot study","volume":"97","author":"Wester","year":"2008","journal-title":"Scand J Surg"},{"key":"2022061713355846100_sct313020-bib-0010","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00268-012-1892-6","article-title":"Intra-arterial allogeneic mesenchymal stem cells for critical limb ischemia are safe and efficacious: report of a phase I study","volume":"37","author":"Das","year":"2013","journal-title":"World J Surg"},{"key":"2022061713355846100_sct313020-bib-0011","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-017-0488-3","article-title":"Development of a surrogate potency assay to determine the angiogenic activity of Stempeucel, a pooled, ex-vivo expanded, allogeneic human bone marrow mesenchymal stromal cell product","volume":"8","author":"Thej","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"2022061713355846100_sct313020-bib-0012","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1634\/stemcells.2007-0226","article-title":"Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis","volume":"25","author":"Wu","year":"2007","journal-title":"Stem Cells"},{"key":"2022061713355846100_sct313020-bib-0013","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2307\/2531248","article-title":"Longitudinal data analysis for discrete and continuous outcomes","volume":"42","author":"Zeger","year":"1986","journal-title":"Biometrics"},{"key":"2022061713355846100_sct313020-bib-0014","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/303728","article-title":"Generalized estimating equations in longitudinal data analysis: a review and recent developments","volume":"2014","author":"Wang","year":"2014","journal-title":"Adv Stat"},{"key":"2022061713355846100_sct313020-bib-0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0140-6736(90)90346-7","article-title":"Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans","volume":"335","author":"Fiessinger","year":"1990","journal-title":"Lancet"},{"key":"2022061713355846100_sct313020-bib-0016","first-page":"420","article-title":"The wound healing effects of Iloprost in patients with Buerger's disease: claudication and prevention of major amputations","volume":"13","author":"Afsharfard","year":"2011","journal-title":"Iran Red Crescent Med J"},{"key":"2022061713355846100_sct313020-bib-0017","doi-asserted-by":"crossref","DOI":"10.3390\/pr8111408","article-title":"Stem cell therapy for thromboangiitis obliterans (Buerger's disease)","volume":"8","author":"Dash","year":"2020","journal-title":"Processes"},{"key":"2022061713355846100_sct313020-bib-0018","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jvs.2003.08.006","article-title":"Clinical and social consequences of Buerger disease","volume":"39","author":"Ohta","year":"2004","journal-title":"J Vasc Surg"},{"key":"2022061713355846100_sct313020-bib-0019","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S1078-5884(97)80017-2","article-title":"Role of infrainguinal bypass in Buerger's disease: an eighteen-year experience","volume":"13","author":"Sasajima","year":"1997","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2022061713355846100_sct313020-bib-0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.avsg.2017.10.022","article-title":"How to treat a patient with thromboangiitis obliterans: a systematic review","volume":"49","author":"Fazeli","year":"2018","journal-title":"Ann Vasc Surg"},{"key":"2022061713355846100_sct313020-bib-0021","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3727\/215517916X693069","article-title":"A prospective, nonrandomized, no placebo-controlled, phase I\/II clinical trial assessing the safety and efficacy of intramuscular injection of autologous adipose tissue-derived mesenchymal stem cells in patients with severe Buerger's disease","volume":"9","author":"Ra","year":"2017","journal-title":"Cell Med"},{"key":"2022061713355846100_sct313020-bib-0022","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-11-143","article-title":"A double blind randomized placebo controlled phase I\/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia","volume":"11","author":"Gupta","year":"2013","journal-title":"J Transl Med"},{"key":"2022061713355846100_sct313020-bib-0023","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","article-title":"A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction","volume":"54","author":"Hare","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2022061713355846100_sct313020-bib-0024","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1182\/blood-2007-10-118273","article-title":"Bone marrow derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature","volume":"111","author":"Au","year":"2008","journal-title":"Blood"},{"key":"2022061713355846100_sct313020-bib-0025","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3727\/096368910X509068","article-title":"Beneficial effects of VEGF secreted from stromal cells in supporting endothelial cell functions: therapeutic implications for critical limb ischemia","volume":"19","author":"Cobellis","year":"2010","journal-title":"Cell Transplant"},{"key":"2022061713355846100_sct313020-bib-0026","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.stem.2012.02.005","article-title":"Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease","volume":"10","author":"Ranganath","year":"2012","journal-title":"Cell Stem Cell"},{"key":"2022061713355846100_sct313020-bib-0027","first-page":"99","article-title":"Evaluation of the secretome profile and functional characteristics of human bone marrow mesenchymal stromal cells-derived conditioned medium suggest potential for skin rejuvenation","volume":"7","author":"Balasubramanian","year":"2017","journal-title":"J Cosmet Dermatological Sci Appl"},{"key":"2022061713355846100_sct313020-bib-0028","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev.cb.11.110195.000445","article-title":"Vasculogenesis","volume":"11","author":"Risau","year":"1995","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2022061713355846100_sct313020-bib-0029","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s001099900019","article-title":"Molecular and biological properties of vascular endothelial growth factor","volume":"77","author":"Ferrara","year":"1999","journal-title":"J Mol Med (Berl)"},{"key":"2022061713355846100_sct313020-bib-0030","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-021-02330-9","article-title":"Human bone marrow-derived, pooled, allogeneic mesenchymal stromal cells manufactured from multiple donors at different times show comparable biological functions in vitro, and in vivo to repair limb ischemia","volume":"12","author":"Thej","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"2022061713355846100_sct313020-bib-0031","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/BF00227451","article-title":"A prospective evaluation of sensitivity and specificity of the ankle\/brachial index in the follow-up of superficial femoral artery occlusions treated by angioplasty","volume":"72","author":"Decrinis","year":"1994","journal-title":"Clin Investig"},{"key":"2022061713355846100_sct313020-bib-0032","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1016\/j.jacc.2004.09.029","article-title":"Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease)","volume":"44","author":"Cooper","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2022061713355846100_sct313020-bib-0033","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/rheumatology\/kel388","article-title":"Thromboangiitis obliterans or Buerger's disease: challenges for the rheumatologist","volume":"46","author":"Pu\u00e9chal","year":"2007","journal-title":"Rheumatology"},{"key":"2022061713355846100_sct313020-bib-0034","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5114\/aoms.2013.39935","article-title":"Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia","volume":"11","author":"Sk\u00f3ra","year":"2015","journal-title":"Arch Med Sci"},{"key":"2022061713355846100_sct313020-bib-0035","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/CIRCINTERVENTIONS.112.968321","article-title":"A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia","volume":"5","author":"Losordo","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"2022061713355846100_sct313020-bib-0036","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(11)60394-2","article-title":"Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia","volume":"377","author":"Belch","year":"2011","journal-title":"Lancet"},{"key":"2022061713355846100_sct313020-bib-0037","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3109\/14653249.2010.507330","article-title":"Defining the risks of mesenchymal stromal cell therapy","volume":"12","author":"Prockop","year":"2010","journal-title":"Cytotherapy"},{"key":"2022061713355846100_sct313020-bib-0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047559","article-title":"Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials","volume":"7","author":"Lalu","year":"2012","journal-title":"PLoS One"},{"key":"2022061713355846100_sct313020-bib-0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2019.100249","article-title":"Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: an updated systematic review and meta-analysis","volume":"19","author":"Thompson","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"12","key":"2022061713355846100_sct313020-bib-0040","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/sctm.21-0197","article-title":"Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease","volume":"10","author":"Gupta","year":"2021","journal-title":"STEM CELLS Transl Med"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/sctm.21-0197","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/sctm.21-0197","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/10\/12\/1602\/44117044\/stcltm_10_12_1602.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/10\/12\/1602\/44117044\/stcltm_10_12_1602.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T13:36:43Z","timestamp":1655473003000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/10\/12\/1602\/6517750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,9,13]]},"published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/sctm.21-0197","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,9,13]]},"assertion":[{"value":"2021-05-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}